Russell Investments Group
NVAX icon

Russell Investments Group’s Novavax NVAX Stock Holding History

Russell Investments Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$850K Buy
90,337
+38,056
+73% +$341K ﹤0.01% 2536
2026
Q1 		$425K Buy
52,281
+13,568
+35% +$123K ﹤0.01% 2565
2025
Q4 		$260K Sell
38,713
-2,591
-6% -$19.5K ﹤0.01% 2744
2025
Q3 		$358K Buy
41,304
+16,747
+68% +$130K ﹤0.01% 2612
2025
Q2 		$155K Buy
24,557
+24,505
+47,125% +$162K ﹤0.01% 2713
2025
Q1 		$333 Hold
52
– – ﹤0.01% 3712
2024
Q4 		$418 Hold
52
– – ﹤0.01% 3627
2024
Q3 		$657 Sell
52
-1,243
-96% -$16.1K ﹤0.01% 3533
2024
Q2 		$16.4K Buy
+1,295
New +$13K ﹤0.01% 2975
2023
Q4 		– Sell
-128
Closed -$927 – 3278
2023
Q3 		$927 Sell
128
-6,392
-98% -$51.1K ﹤0.01% 3349
2023
Q2 		$48.4K Sell
6,520
-585
-8% -$4.6K ﹤0.01% 2726
2023
Q1 		$49.2K Sell
7,105
-3,549
-33% -$32.7K ﹤0.01% 2715
2022
Q4 		$110K Buy
10,654
+6,520
+158% +$115K ﹤0.01% 2657
2022
Q3 		$75K Sell
4,134
-546
-12% -$23.7K ﹤0.01% 2710
2022
Q2 		$240K Sell
4,680
-2,532
-35% -$131K ﹤0.01% 2502
2022
Q1 		$529K Sell
7,212
-11,370
-61% -$1.01M ﹤0.01% 2208
2021
Q4 		$2.67M Sell
18,582
-172
-0.9% -$29.6K ﹤0.01% 1646
2021
Q3 		$3.88M Sell
18,754
-7,513
-29% -$1.66M 0.01% 1399
2021
Q2 		$5.58M Sell
26,267
-16,682
-39% -$3.06M 0.01% 1278
2021
Q1 		$7.78M Buy
42,949
+7,369
+21% +$1.47M 0.01% 1101
2020
Q4 		$3.97M Sell
35,580
-5,081
-12% -$540K 0.01% 1369
2020
Q3 		$4.4M Buy
40,661
+36,540
+887% +$4.45M 0.01% 1211
2020
Q2 		$343K Buy
+4,121
New +$158K ﹤0.01% 2529
2019
Q1 		– Sell
-1,510
Closed -$56K – 2981
2018
Q4 		$56K Buy
+1,510
New +$58.5K ﹤0.01% 2786
2018
Q3 		– Sell
-24,858
Closed -$666K – 2998
2018
Q2 		$666K Sell
24,858
-1,823
-7% -$61.6K ﹤0.01% 2301
2018
Q1 		$1.12M Buy
26,681
+19,251
+259% +$773K ﹤0.01% 2160
2017
Q4 		$193K Buy
+7,430
New +$181K ﹤0.01% 2676

Other funds holding NVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Russell Investments Group's NVAX Position: Q2 2026 in Review

Russell Investments Group increased its Novavax (NVAX) stake by 73% in Q2 2026, buying an estimated $341K and bringing the position to 90,337 shares worth $850K. The position accounts for ﹤0.01% of the portfolio, ranked #2536.

Russell Investments Group first reported a position in NVAX in Q4 2017 and has held it in 27 quarters since. The position peaked at $7.78M in Q1 2021. 115 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Russell Investments Group held 90,337 shares of Novavax worth $850K as of Q2 2026.
  • Russell Investments Group bought 38,056 Novavax shares in Q2 2026, an estimated $341K.
  • Novavax made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2536 holding.
  • Russell Investments Group first reported a position in Novavax in Q4 2017 and has held it in 27 quarters since.
  • Russell Investments Group's Novavax position peaked at $7.78M in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.